Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07228845 · ClinicalTrials.gov registry record · NA

Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss

A NA study, sponsored by University of Arizona.

Recruiting
Registry status
NA
Development phase
32
Enrollment target

NCT07228845: Recruiting NA study, sponsored by University of Arizona.

NCT07228845 is a NA study that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07228845, a NA study, is actively recruiting participants, sponsored by University of Arizona.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

Access to affordable and timely hearing healthcare remains a major challenge for many individuals, partly due to the high cost and long turnaround time. This study will explore whether 3D-printed ear tips perform as well as or better than standard ear tips in terms of sound quality, comfort, and fit over a prolonged duration in a sample of individuals with bilateral hearing loss. It will also compare how long each method takes to make and how much each costs.

Primary Outcome

A validated questionnaire, Outer EAR, will be used to elicit patient perception of physical comfort, acoustic comfort, quality of voice, and overall self-perceived satisfaction. Includes 6 items (5 levels) , with 5 representing best possible function/rating.

Interventions

  • DEVICE BTE hearing aids with compatible ear tips (Third-party, FlexResin, Resin)
  • DEVICE BTE hearing aids with compatible ear tips (FlexResin, Resin, Third-party, FlexResin)
  • DEVICE BTE hearing aids with compatible ear tips (Resin, Third-party, FlexRes)

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2026-03-15
Est. Completion 2027-04-25
Phase NA
University of Arizona

349 total trials

What NCT07228845 shows while recruiting

NCT07228845 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which BTE hearing aids with compatible ear tips (Third-party, FlexResin, Resin) is the first listed.

NCT07228845 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07228845 about?

NCT07228845 is a clinical study titled "Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss". Access to affordable and timely hearing healthcare remains a major challenge for many individuals, partly due to the high cost and long turnaround time. This study will explore whether 3D-printed ear tips perform as well as or better than standard ear tips in terms of sound quality, comfort, and fit...

What is the current status of trial NCT07228845?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2026-03-15. Estimated completion is 2027-04-25.

What interventions are being tested in trial NCT07228845?

The interventions under investigation include: BTE hearing aids with compatible ear tips (Third-party, FlexResin, Resin) (DEVICE), BTE hearing aids with compatible ear tips (FlexResin, Resin, Third-party, FlexResin) (DEVICE), BTE hearing aids with compatible ear tips (Resin, Third-party, FlexRes) (DEVICE).

Who is sponsoring clinical trial NCT07228845?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07228845's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07228845, the US trial registry maintained by the National Library of Medicine. NCT07228845 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.